L.HadjisavvasA.MalasS.VontaI.et al (2013)
However, if you have not lost at least 5% of your original body weight after 12 weeks of using the maintenance dose, you should stop taking Semaglutide
Figure from van der Aart-van der Beek AB, Nat Rev Nephrol, 2020 The Study Methods This was an international, event-driven, double-blind, parallel-group, randomized, placebo-controlled trial conducted at 387 sites in 28 countries comparing semaglutide to placebo in patients with T2DM and CKD, both being treated with baseline standard of care
10.24976/Discov.Med.202436183.62 52 SchmiegeP.LiX
J Am Coll Cardiol 2021;77:1381-92
In such combinations, GHK-Cu supports tissue repair, inflammation regulation, and connective tissue health, while GH-based peptides assist with metabolic efficiency, recovery capacity, and body composition support